TAFAZZIN and hepatocellular carcinoma: About 30% of hepatocellular cancer cases show an inactivation of the tumor-suppressing proteins Mst1 and Mst2, and consequently, a high YAP/TAZ activity, indicating the contribution of Hippo in hepatocellular cancer [242].